Mukka Proteins

Has Mukka Proteins declared dividend?

No Dividend History Available

Who are the peers of the Mukka Proteins?

Mukka Proteins' peers include Godavari Bioref., HMA Agro Inds., Aayush Wellness, and others, with Aayush Wellness showing excellent management risk and the highest 1-year return at 1374.42%, while Mukka Proteins has a 1-year return of -45.04%. Growth is good for Mukka Proteins and a few others, but its capital structure is below average compared to peers.

Peers: The peers of Mukka Proteins are Godavari Bioref., HMA Agro Inds., Andrew Yule & Co, Aayush Wellness, Jindal Photo, Vadilal Enterp., SKM Egg Prod., Foods & Inns, and Apex Frozen Food.<BR><BR>Quality Snapshot: Excellent management risk is observed at Aayush Wellness and the rest have Average management risk. Growth is Good at Mukka Proteins, Vadilal Enterp., SKM Egg Prod., and Aayush Wellness, while the rest show Below Average or Average growth. Capital Structure is Good at Aayush Wellness, Vadilal Enterp., and SKM Egg Prod., while Below Average capital structure is found at Mukka Proteins, Andrew Yule & Co, HMA Agro Inds., Jindal Photo, Foods & Inns, and the rest.<BR><BR>Return Snapshot: Aayush Wellness has the highest 1-year return at 1374.42%, while HMA Agro Inds. has the lowest at -42.55%, with Mukka Proteins' 1-year return of -45.04% being lower than both. Additionally, Jindal Photo and Foods & Inns are among the peers with negative six-month returns.

What does Mukka Proteins do?

Mukka Proteins Ltd is a micro-cap FMCG company that specializes in protein products, with recent net sales of ₹3,816 Cr and a net profit of ₹136 Cr as of March 2025. The company has a market cap of ₹897 Cr and key financial metrics include a P/E ratio of 19.00 and a debt-equity ratio of 0.93.

Overview:<BR>Mukka Proteins Ltd operates in the FMCG industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Mukka Proteins Limited was originally incorporated as "Mukka Sea Food Industries" in Karnataka on March 13, 2003. It was converted from a partnership firm to a private company on November 04, 2010. The latest quarterly results report net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 3,816 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 136 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 897 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 19.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.93 <BR>Return on Equity: 10.47% <BR>Price to Book: 2.03 <BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the top shareholders of the Mukka Proteins?

The top shareholders of Mukka Proteins include Mohammed Haris K, who holds 30.23%, followed by 7 Foreign Institutional Investors with 2.63%, and Neomile Growth Fund - Series I with 1.98%. Individual investors own 19.85%, with no pledged promoter holdings or mutual fund investments.

The top shareholders of Mukka Proteins include the promoters, who hold the majority of the shares. The promoter with the highest holding is Mohammed Haris K, who owns 30.23% of the company. Additionally, there are 7 Foreign Institutional Investors (FIIs) holding a combined 2.63% of the shares. The highest public shareholder is Neomile Growth Fund - Series I, which holds 1.98%. Individual investors collectively own 19.85% of the company. There are no pledged promoter holdings, and no mutual funds are currently invested in Mukka Proteins.

How big is Mukka Proteins?

As of 24th July, Mukka Proteins Ltd has a market capitalization of 875.00 Cr, with recent net sales of 1006.42 Cr and a net profit of 46.16 Cr. The company reported shareholder's funds of 396.09 Cr and total assets of 940.79 Cr for the annual period ending March 2024.

As of 24th July, Mukka Proteins Ltd has a market capitalization of 875.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Mukka Proteins reported Net Sales of 1006.42 Cr and a Net Profit of 46.16 Cr.<BR><BR>For the latest annual period ending March 2024, the company had Shareholder's Funds of 396.09 Cr and Total Assets amounting to 940.79 Cr.

How has been the historical performance of Mukka Proteins?

Mukka Proteins has shown fluctuating performance, with net sales declining to 1,006.42 Cr in March 2025 from 1,379.83 Cr in March 2024, alongside decreases in profitability, while total assets increased to 1,076.32 Cr. The company faced a challenging year marked by negative cash flow and reduced profits.

Answer:<BR>The historical performance of Mukka Proteins shows a fluctuating trend in net sales and profitability over the years, with a notable decline in the most recent fiscal year.<BR><BR>Breakdown:<BR>Mukka Proteins reported net sales of 1,006.42 Cr for the year ending March 2025, a decrease from 1,379.83 Cr in March 2024 and 1,177.12 Cr in March 2023, but an increase from 770.50 Cr in March 2022. Total operating income mirrored this trend, reaching 1,006.42 Cr in March 2025. The company's total expenditure, excluding depreciation, was 911.53 Cr in March 2025, down from 1,274.36 Cr in March 2024, while operating profit (PBDIT) was 110.01 Cr, showing a decline from 121.79 Cr in the previous year. Profit before tax also decreased to 59.20 Cr in March 2025 from 84.35 Cr in March 2024. Consequently, profit after tax fell to 47.03 Cr from 71.20 Cr. The company's total assets increased to 1,076.32 Cr in March 2025, up from 940.79 Cr in March 2024, and total liabilities also rose to 1,076.32 Cr from 940.79 Cr. Cash flow from operating activities remained negative at -111.00 Cr in March 2025, although cash and cash equivalents decreased to 3.00 Cr from 94.00 Cr in March 2024. Overall, Mukka Proteins experienced a challenging year with declining sales and profits, despite an increase in total assets and liabilities.

Is Mukka Proteins overvalued or undervalued?

As of November 14, 2025, Mukka Proteins is considered very attractive and undervalued with a PE ratio of 16.74 and an EV to EBITDA of 12.74, outperforming peers like Avanti Feeds and Apex Frozen Foods, and has delivered an 8.16% return compared to the Sensex's 1.62%.

As of 14 November 2025, Mukka Proteins has moved from an attractive to a very attractive valuation grade. The company is currently considered undervalued, supported by a PE ratio of 16.74, an EV to EBITDA ratio of 12.74, and a PEG ratio of 0.00, indicating strong potential for growth relative to its price. <BR><BR>In comparison with peers, Avanti Feeds has a PE ratio of 16.54 and an EV to EBITDA of 10.04, while Apex Frozen Foods shows a significantly higher PE ratio of 43.53, suggesting that Mukka Proteins is positioned favorably within its industry. Additionally, the company's recent stock performance has outpaced the Sensex over the past week, with an 8.16% return compared to the Sensex's 1.62%, reinforcing the notion of its undervaluation.

Is Mukka Proteins technically bullish or bearish?

As of December 3, 2025, Mukka Proteins is in a mildly bearish trend, supported by bearish daily moving averages and Bollinger Bands, despite some mixed signals from the MACD and RSI across different timeframes.

As of 3 December 2025, the technical trend for Mukka Proteins has changed from sideways to mildly bearish. The current stance is bearish, with key indicators supporting this view. The daily moving averages are bearish, and both the weekly and monthly Bollinger Bands are also bearish. Although the weekly MACD and KST are mildly bullish, the overall sentiment is tempered by the bearish signals from the moving averages and Bollinger Bands. The RSI shows no signal on the weekly timeframe, while it is bullish on the monthly, indicating mixed signals across different timeframes. Overall, the bearish trend is currently stronger, reflecting the recent price decline from the previous close.

When is the next results date for Mukka Proteins Ltd?

The next results date for Mukka Proteins Ltd is 12 February 2026.

The next results date for Mukka Proteins Ltd is scheduled for 12 February 2026.

Are Mukka Proteins Ltd latest results good or bad?

Mukka Proteins Ltd's latest results show impressive revenue growth with a consolidated net profit of ₹23.75 crore, but significant concerns arise from a sharp decline in operating margins to 7.16% and high debt levels, indicating potential challenges in sustaining profitability. Investors should be cautious about the company's operational difficulties despite the strong sales figures.

Mukka Proteins Ltd's latest results present a mixed picture. On one hand, the company achieved a remarkable consolidated net profit of ₹23.75 crore in Q3 FY26, which is a substantial increase of 303.91% compared to the previous quarter. Additionally, net sales soared to ₹653.50 crore, reflecting a 167.19% increase quarter-on-quarter and a strong 115.57% year-on-year growth.<BR><BR>However, the positive revenue growth comes with significant concerns regarding profitability. The operating margin has contracted sharply to 7.16%, down from 13.96% in the same quarter last year, indicating challenges in maintaining profitability despite the impressive sales figures. This margin compression raises questions about the company's pricing power and cost management in a competitive seafood processing industry.<BR><BR>Furthermore, while the profit after tax margin improved sequentially, it still decreased year-on-year, highlighting ongoing challenges in converting revenue growth into sustainable profits. The company's high debt levels and the substantial interest costs also add to the financial strain.<BR><BR>In summary, while Mukka Proteins has demonstrated explosive revenue growth, the significant margin compression and financial leverage issues suggest that the overall results are not entirely positive. Investors should be cautious and consider the sustainability of this growth in the context of the company's operational challenges.

Should I buy, sell or hold Mukka Proteins Ltd?

Why is Mukka Proteins Ltd falling/rising?

As of 17-Mar, Mukka Proteins Ltd's stock price is rising to 21.38, indicating a potential shift in market sentiment after three days of decline. Despite underperforming its sector, the increase in price and delivery volume suggests a short-term recovery and heightened investor participation.

As of 17-Mar, Mukka Proteins Ltd's stock price is rising, currently at 21.38, with a change of 0.28 (1.33%) upwards. This increase follows a trend reversal after three consecutive days of decline, indicating a potential shift in market sentiment. Despite the stock's recent performance, which shows it has underperformed its sector by 1.34%, the rise in price today suggests a positive reaction from investors. Additionally, there has been a notable increase in delivery volume, which rose by 8.07% compared to the 5-day average, indicating heightened investor participation. However, it is important to note that the stock is still trading below its moving averages across various time frames, which may suggest ongoing challenges. Overall, the current rise in price can be attributed to a short-term recovery after a period of decline and increased investor activity.

Why is Mukka Proteins Ltd falling/rising?

As of 18-Mar, Mukka Proteins Ltd's stock price is rising to 21.85, driven by positive financial results and recent gains. However, it remains below moving averages and faces long-term challenges due to declining investor participation and weak fundamentals.

As of 18-Mar, Mukka Proteins Ltd's stock price is rising, currently at 21.85, with a change of 0.47 (2.2%) upward. This increase can be attributed to a few key factors. Firstly, the stock has outperformed its sector today by 3.09% and has been gaining for the last two days, accumulating a total return of 3.55% during this period. Additionally, the company recently declared positive financial results for December 2025, marking a significant turnaround after seven consecutive negative quarters. The profit after tax for the quarter was reported at Rs 23.75 crore, showing a remarkable growth of 101.1% compared to the previous four-quarter average, and net sales reached their highest at Rs 653.50 crore.<BR><BR>However, it is important to note that despite the recent rise, the stock is still trading below its moving averages across various time frames, indicating a longer-term downward trend. Furthermore, there has been a notable decline in investor participation, with delivery volume falling by 45.82% against the five-day average, which could signal caution among investors. Overall, while the stock is currently experiencing a rise due to recent positive results and short-term gains, the long-term outlook remains challenged by weak fundamentals and declining institutional interest.

Why is Mukka Proteins Ltd falling/rising?

As of 19-Mar, Mukka Proteins Ltd's stock price is at Rs 21.20, down 2.89%, reflecting a significant decline over various time frames, including a 37.65% drop over the past year. Despite recent positive quarterly results, weak long-term fundamentals and decreased institutional investor confidence contribute to the bearish outlook.

As of 19-Mar, Mukka Proteins Ltd's stock price is falling, currently at Rs 21.20, which reflects a decrease of Rs 0.63 or 2.89%. This decline is part of a broader trend, as the stock has underperformed significantly over various time frames, including a 1-week drop of 5.57% and a 1-month decline of 10.13%. Year-to-date, the stock has decreased by 11.70%, and over the past year, it has plummeted by 37.65%, contrasting sharply with the Sensex, which has only fallen by 1.65% in the same period.<BR><BR>The stock is currently trading close to its 52-week low, just 4.72% above Rs 20.2. Despite a recent outperformance against its sector by 1.44%, the overall trend indicates a reversal after two days of gains, suggesting a lack of sustained momentum. Additionally, Mukka Proteins is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish outlook.<BR><BR>Investor sentiment appears to be affected by weak long-term fundamentals, including a -4.98% compound annual growth rate in operating profits over the last five years and a high Debt to EBITDA ratio of 5.26 times, indicating challenges in servicing debt. Furthermore, institutional investor participation has decreased, with a reduction of 1.5% in their stake over the previous quarter, reflecting a lack of confidence from more sophisticated investors.<BR><BR>While the company recently reported positive quarterly results, including a 137.6% growth in net sales and a 101.1% increase in profit after tax, these improvements come after seven consecutive quarters of negative performance. The stock's valuation remains attractive compared to peers, but the overall negative sentiment and poor historical performance contribute to the current decline in stock price.

Why is Mukka Proteins Ltd falling/rising?

As of 20-Mar, Mukka Proteins Ltd's stock price is Rs 21.05, reflecting a decline of 0.66%. The stock has significantly underperformed, with a 36.96% drop over the past year, and shows bearish trends with declining investor interest and weak long-term fundamentals.

As of 20-Mar, Mukka Proteins Ltd's stock price is falling, currently at Rs 21.05, which reflects a decrease of Rs 0.14 or 0.66%. The stock has been underperforming significantly, with a decline of 3.44% over the past week and a notable drop of 10.62% over the past month. Year-to-date, the stock has fallen by 12.33%, and it has experienced a substantial decline of 36.96% over the past year, contrasting sharply with the Sensex, which has only decreased by 2.38% during the same period.<BR><BR>Today's performance indicates that the stock is close to its 52-week low, being just 4.04% away from Rs 20.2. It has underperformed its sector by 3.23% today and has seen consecutive losses over the last two days, accumulating a total decline of 3.57%. Furthermore, Mukka Proteins is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend.<BR><BR>Investor participation has also been declining, with delivery volume dropping by 30.62% compared to the 5-day average, indicating reduced interest from traders. Additionally, institutional investors have decreased their stake in the company by 1.5% over the previous quarter, reflecting a lack of confidence in the stock's future performance.<BR><BR>While the company recently reported positive results after several negative quarters, including significant growth in profit before tax and net sales, the overall long-term fundamentals remain weak. The company has shown a -4.98% compound annual growth rate in operating profits over the last five years and has a high debt-to-EBITDA ratio of 5.26 times, which raises concerns about its ability to service debt. These factors contribute to the stock's declining price, as investors weigh the risks against the potential for recovery.

Why is Mukka Proteins Ltd falling/rising?

As of 23-Mar, Mukka Proteins Ltd's stock price is at Rs. 20.48, reflecting a 2.71% decrease and a downward trend with a recent 52-week low of Rs. 20.2. The stock's decline is influenced by weak sector performance, reduced investor participation, and concerning long-term fundamentals despite some recent positive financial results.

As of 23-Mar, Mukka Proteins Ltd's stock price is falling, currently at Rs. 20.48, which reflects a decrease of Rs. 0.57 or 2.71%. The stock has been on a downward trend, having lost 6.18% over the last three days and is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. <BR><BR>Additionally, the stock has recently hit a new 52-week low of Rs. 20.2, indicating a significant decline in value. The aquaculture sector, in which Mukka operates, has also experienced a downturn, falling by 7.5%. This broader sector weakness may contribute to the stock's decline. <BR><BR>Investor participation has decreased, with delivery volume dropping by 29.62% compared to the 5-day average, suggesting a lack of confidence among investors. Institutional investors have reduced their stake by 1.5% in the previous quarter, indicating a lack of support from larger, more informed investors. <BR><BR>Despite some positive financial results reported in December 2025, including a 137.6% growth in net sales and a 101.1% increase in profit after tax compared to previous quarters, the overall long-term fundamentals remain weak. The company has shown a -4.98% compound annual growth rate in operating profits over the last five years and has a high debt-to-EBITDA ratio of 5.26 times, which raises concerns about its ability to service debt. <BR><BR>Overall, the combination of recent price declines, poor long-term performance, reduced investor participation, and sector challenges contributes to the falling stock price of Mukka Proteins Ltd.

Why is Mukka Proteins Ltd falling/rising?

As of 24-Mar, Mukka Proteins Ltd's stock price is Rs. 20.64, showing a slight recovery after recent declines but remains below all moving averages and has underperformed its sector. Despite increased investor participation and positive financial results, concerns about long-term fundamentals and declining institutional confidence persist.

As of 24-Mar, Mukka Proteins Ltd's stock price is currently at Rs. 20.64, reflecting a change of 0.19 (0.93%) upward. This rise comes after a trend reversal, as the stock has gained after three consecutive days of decline. However, it is important to note that the stock has recently hit a new 52-week and all-time low of Rs. 20, indicating significant downward pressure prior to this slight recovery.<BR><BR>Despite the recent uptick, the stock has underperformed its sector by 5.06% today and is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests that the overall trend remains weak. Additionally, the stock has experienced a considerable decline over longer periods, with a 39.12% drop in the past year and an 11.42% decline over the past month.<BR><BR>On a more positive note, there has been a rise in investor participation, with delivery volume increasing by 49.86% compared to the 5-day average, which may indicate growing interest from retail investors. Furthermore, the company recently reported positive financial results, including a significant growth in profit after tax and net sales, which could be contributing to the current rise in stock price.<BR><BR>However, the overall sentiment remains cautious due to the company's weak long-term fundamentals, including a negative CAGR growth in operating profits over the last five years and a high debt-to-EBITDA ratio, which raises concerns about its ability to service debt. Additionally, institutional investors have decreased their stakes, indicating a lack of confidence in the company's future performance.<BR><BR>In summary, while Mukka Proteins Ltd's stock is experiencing a brief rise, the underlying factors suggest a complex situation with significant challenges that could impact its future performance.

Why is Mukka Proteins Ltd falling/rising?

As of 25-Mar, Mukka Proteins Ltd's stock price is Rs 20.50, reflecting a decline of 0.19%. The stock has significantly underperformed, with a year-to-date drop of 14.62% and a 38.81% decline over the past year, alongside weak fundamentals and declining investor interest.

As of 25-Mar, Mukka Proteins Ltd's stock price is falling, currently at Rs 20.50, reflecting a decrease of Rs 0.04 or 0.19%. The stock has underperformed significantly in various time frames, with a year-to-date decline of 14.62% compared to a 11.67% drop in the Sensex. Over the past year, the stock has plummeted by 38.81%, while the broader market has only seen a 3.52% decline.<BR><BR>Today's performance indicates that the stock is close to its 52-week low, being only 2.44% away from it. Additionally, it has underperformed its sector by 6.75% today. The stock is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which is a bearish signal.<BR><BR>Investor participation is also declining, with delivery volume dropping by 12.37% against the 5-day average. Furthermore, institutional investors have reduced their stake by 1.5% in the last quarter, indicating a lack of confidence in the stock's future performance. <BR><BR>Despite the company reporting positive results in December 2025 after a series of negative quarters, the long-term fundamentals remain weak, with a 4.98% compound annual growth rate (CAGR) decline in operating profits over the last five years and a high debt-to-EBITDA ratio of 5.26 times. This suggests that the company struggles to service its debt, contributing to the negative sentiment surrounding the stock. Overall, the combination of poor performance metrics, declining investor interest, and weak fundamentals is driving the stock price down.

Which are the latest news on Mukka Proteins?